Stefan Oschmann
Chief Executive Officer bei Oschmann Comfortbetten GmbH
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Marcus Kuhnert | M | 56 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | 10 Jahre |
Karl-Ludwig Kley | M | 72 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.
Ludwig-Maximilians-Universität München
| 15 Jahre |
Helga Rübsamen-Schaeff | M | 75 |
Aicuris Anti-Infective Cures AG
Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The private company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | 18 Jahre |
Helene von Roeder | F | 53 | 5 Jahre | |
Jonathan Peacock | M | 66 | 3 Jahre | |
Michael Kleinemeier | M | 67 | 5 Jahre | |
Larry G. Edwards | M | 52 |
Aicuris Anti-Infective Cures AG
Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The private company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | 17 Jahre |
Albert Bourla | M | 62 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Simon Thelen | M | 44 | 5 Jahre | |
Holger Zimmermann | M | - |
Aicuris Anti-Infective Cures AG
Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The private company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | 9 Jahre |
Christian Kohlpaintner | M | 61 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.
Technische Universität München
| 7 Jahre |
Paola Ricci | F | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | - |
Peter Guenter | M | 61 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | 3 Jahre |
Marie-Laure Jeanne Antoinette Pochon | F | 65 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | 12 Jahre |
Jürgen Glaser | M | 61 | 12 Jahre | |
Franklin Clyburn | M | 59 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | 14 Jahre |
Dieter Weinand | M | 63 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | - |
Daniel Thelen | M | - | 5 Jahre | |
Wolfgang Plischke | M | 72 |
Paul Ehrlich-Foundation
| - |
Danny Bar-Zohar | M | - | 4 Jahre | |
Juan Francisco Llamazares Vegh | M | - |
Stämm Biotech
Stämm Biotech Miscellaneous Commercial ServicesCommercial Services Stämm Biotech designs novel bio production system that leverages microfluidics and electroporation. It helps to solve the main constraint of the biotech industries. The company was founded by Federico D'Alvia Vegh and Juan Francisco Llamazares Vegh in 2014 and is headquartered in San Francisco, CA. | 10 Jahre |
Federico D'Alvia Vegh | M | - |
Stämm Biotech
Stämm Biotech Miscellaneous Commercial ServicesCommercial Services Stämm Biotech designs novel bio production system that leverages microfluidics and electroporation. It helps to solve the main constraint of the biotech industries. The company was founded by Federico D'Alvia Vegh and Juan Francisco Llamazares Vegh in 2014 and is headquartered in San Francisco, CA. | 10 Jahre |
Sascha Held | M | - | 5 Jahre | |
Renate Koehler | M | - | 5 Jahre | |
Frank Vrancken Peeters | M | - |
Springer Nature AG & Co. KGaA
Springer Nature AG & Co. KGaA Publishing: Books/MagazinesConsumer Services Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany. | 5 Jahre |
Anne Lange | F | - | 5 Jahre | |
Peter Emanuel Merck | M | - | 5 Jahre | |
Susan Gasser | M | 69 | 3 Jahre | |
Tom Glocer | M | 63 | 17 Jahre | |
Dalton Smart | M | 58 | 15 Jahre | |
Matthias Zachert | M | 56 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | 4 Jahre |
Belén Garijo López | M | 62 | 4 Jahre | |
Caroline Litchfield | F | 55 | 34 Jahre | |
Marc M. P. de Garidel | M | 66 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | 10 Jahre |
Ulf Arne Wiinberg | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | - |
Kurt Bock | M | 65 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | 13 Jahre |
Ian Read | M | 71 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | - |
Patricia Russo | F | 71 | 29 Jahre | |
Peter Wendell | M | 73 | 21 Jahre | |
Walter Galinat | M | 68 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | - |
Bernhard Scheifele | M | 66 |
Springer Nature AG & Co. KGaA
Springer Nature AG & Co. KGaA Publishing: Books/MagazinesConsumer Services Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany. | 6 Jahre |
Klaus Engel | M | 67 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | - |
Elmar Pankau | M | 57 |
Malteser Deutschland gGmbH
Malteser Deutschland gGmbH Miscellaneous Commercial ServicesCommercial Services Malteser Deutschland gGmbH engages in the management and operation of medical and nursing care institutions. These include hospitals, senior homes, nursing facilities, and stationary hospices. The company was founded on May 3, 1999 and is headquartered in Cologne, Germany. | 5 Jahre |
Peter Mueller | M | 68 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | - |
Andreas Krebs | M | 65 |
Paul Ehrlich-Foundation
| - |
Sean Marett | M | 59 |
Aicuris Anti-Infective Cures AG
Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The private company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | 3 Jahre |
Hans Jörg Reinhardt | M | 68 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 14 Jahre |
Anno Borkowsky | M | 65 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | - |
Ulf Reermann | M | 53 |
Malteser Deutschland gGmbH
Malteser Deutschland gGmbH Miscellaneous Commercial ServicesCommercial Services Malteser Deutschland gGmbH engages in the management and operation of medical and nursing care institutions. These include hospitals, senior homes, nursing facilities, and stationary hospices. The company was founded on May 3, 1999 and is headquartered in Cologne, Germany. | 5 Jahre |
Bettina Felten | F | - |
Springer Nature AG & Co. KGaA
Springer Nature AG & Co. KGaA Publishing: Books/MagazinesConsumer Services Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany. | 6 Jahre |
Ewald Walgenbach | M | 65 |
Springer Nature AG & Co. KGaA
Springer Nature AG & Co. KGaA Publishing: Books/MagazinesConsumer Services Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany. | 9 Jahre |
Neil Weir | M | - |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | - |
Andreas Fibig | M | 62 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | - |
Matthias J. Heinzel | M | 57 | 5 Jahre | |
Jens Herbert Schwanewedel | M | 56 |
Springer Nature AG & Co. KGaA
Springer Nature AG & Co. KGaA Publishing: Books/MagazinesConsumer Services Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany. | 9 Jahre |
Holger Zinke | M | 61 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | - |
Martin Brudermüller | M | 63 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | 9 Jahre |
Antonio Esteve Cruella | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Jean-Sébastien Jacques | M | 53 |
European Roundtable of Industrialists
| 6 Jahre |
Günter von Au | M | 73 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | - |
Rainier van Roessel | M | 66 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | - |
Sunao Manabe | M | 69 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 1 Jahre |
Patrick Thomas | M | 67 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | - |
Olivier Brandicourt | M | 68 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Jorge Gallardo Ballart | M | 82 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 20 Jahre |
Giovanni Caforio | M | 59 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | - |
Simone Menne | F | 63 |
Springer Nature AG & Co. KGaA
Springer Nature AG & Co. KGaA Publishing: Books/MagazinesConsumer Services Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany. | 6 Jahre |
Tapan Durgadas Ray | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Roger Connor | M | - |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Stefan von Holtzbrinck | M | - |
Springer Nature AG & Co. KGaA
Springer Nature AG & Co. KGaA Publishing: Books/MagazinesConsumer Services Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany. | 9 Jahre |
Axel Claus Heitmann | M | 64 |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | 18 Jahre |
Ian Ragan | M | - |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Robert P. Luciano | M | - | 23 Jahre | |
Richard Kogan | M | 81 | 21 Jahre | |
Kenneth Frazier | M | 69 | 30 Jahre | |
P. Vagelos | M | 94 | 19 Jahre | |
Michael Kemmer | M | 67 |
Ludwig-Maximilians-Universität München
| 5 Jahre |
Rehan Verjee | M | 43 | 6 Jahre | |
Raymond Gilmartin | M | 82 | 2 Jahre | |
Fred Hassan | M | 78 | 6 Jahre | |
Christian Rudolf Näther | M | 58 |
Ludwig-Maximilians-Universität München
| 8 Jahre |
Richard Clark | M | 77 | 6 Jahre | |
Dominique Mohabeer | M | 61 |
Ludwig-Maximilians-Universität München
| 10 Jahre |
Michael Deichsel | M | 69 |
Technische Universität München
| 5 Jahre |
Fiona du Monceau-de Hemptinne | F | 46 | 3 Jahre | |
Jean-Marie Canan | M | 68 | 5 Jahre | |
Peter Kossubek | M | 70 |
Ludwig-Maximilians-Universität München
| 8 Jahre |
Benjamin Winograd | M | 63 |
Technische Universität München
| 4 Jahre |
Paul Friedrich Lerbinger | M | 68 |
Ludwig-Maximilians-Universität München
| 7 Jahre |
Anton Mindl | M | 67 |
Technische Universität München
| 8 Jahre |
Herbert Diess | M | 65 |
Technische Universität München
| 9 Jahre |
Craig Thompson | M | 71 | 10 Jahre | |
Wolfgang Schäfer | M | 65 |
Ludwig-Maximilians-Universität München
| 5 Jahre |
Carlos Eduardo Represas de Almeida | M | 78 | - | |
Heinrich Hiesinger | M | 64 |
Technische Universität München
| 4 Jahre |
Richard Mayer | M | 62 |
Ludwig-Maximilians-Universität München
| 6 Jahre |
Donald S. Brooks | M | 88 | - | |
William N. Kelley | M | 84 | - | |
Leslie Brun | M | 72 | 13 Jahre | |
Christoph Walbrecht | M | - |
Ludwig-Maximilians-Universität München
| 6 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Deutschland | 57 | 57,00% |
Vereinigte Staaten | 23 | 23,00% |
Belgien | 16 | 16,00% |
Schweiz | 12 | 12,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Stefan Oschmann
- Persönliches Netzwerk